Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Equipment >

Ekso Bionics Holdings, Inc. (EKSO)

Add EKSO Price Alert      Hide Sticky   Hide Intro
Moderator: skepticone, Lion33, Rhetorical
Search This Board: 
Last Post: 12/10/2017 8:11:02 PM - Followers: 108 - Board type: Free - Posts Today: 0

Industry leaders in healthcare, military, and industrial exoskeletons 
                                         (Continue below to message board)                                  


Ekso GT (Healthcare):

Ekso GT is a robotic exoskeleton used for over-ground gait training in people with a neurological diagnosis. It helps patients re-learn the correct step patterns and weight shifts involved in walking, potentially mitigating compensatory behaviors.

Ekso GT’s Variable Assist software allows physical therapists to determine how much power is provided to either side of the person’s body. This balances the physical effort that the person exerts with the amount of help that he or she needs to achieve a more normalized gait. It also makes the device suitable for a broad spectrum of neuro-rehabilitation activities and keeps individuals challenged as they progress through their rehabilitation.

For people who thought they would never stand or walk again, Ekso GT provides hope for greater mobility and independence.

[Christina Kwasnica, M.D., medical director for the Barrow Neuro Rehabilitation Center, notes, “The robotic device allows us to get patients up on their feet earlier. The gains we see are overwhelming and the positive effects on a patient’s mood and motivation is unbelievable.”

Ekso Bionics(TM) Receives Its First NIH Grant (Oct 28, 2014):
RICHMOND, Calif., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, announced today that it has been awarded a P20 Exploratory Grant from the National Institutes of Health (NIH) to continue the development of an exoskeleton prototype for children. This work will be done in collaboration with the pediatric rehabilitation department at the UCSF Benioff Children's Hospital Oakland and will consist of Ekso Bionics developing a pediatric version of its Ekso GT™ robotic exoskeleton. Working with UCSF Benioff Children's Hospital Oakland allows for the effective integration of advanced robotics into a world-class pediatric rehabilitative practice.

Ekso Bionics Licences Intellectual Property to Ottobock (Nov 3, 2014):

Ekso GT™ Robotic Exoskeleton Cleared by FDA for Use With Stroke and Spinal Cord Injury Patients (Apr 4, 2016):

EKSO Bionics Robotic Exoskeletons Gain Global Connectivity With Vodafone IoT Technology (Jun 7, 2016):

Ekso Bionics® Launches Smart Assist (Oct 4, 2016):

Ekso Bionics® Launches EksoPulse Cloud-Based Analytics (Feb 9, 2017):

Ekso Bionics and Vodafone Receive 2016 HealthTechZone Telehealth Award (Apr 7, 2017):

Ekso: T.A.L.O.S. & Warrior Web (D.O.D.):

T.A.L.O.S. (Tactical Assault LIght Operator Suit):
Ekso Labs was awarded an Other Transaction for Prototypes Agreement from U.S. Special Operations Command (SOCOM) to develop technologies for their Tactical Assault Light Operator Suit (TALOS) project. TALOS is a futuristic assault suit that promises to provide superhuman strength with superior mobility and protection, and is often referred to as the "Iron Man" suit. The exoskeleton chassis, which Ekso Labs is developing, will be designed to allow soldiers to carry out their mission with agility, while carrying hundreds of pounds of load. The TALOS project is integrating other functional elements, including armor and systems, to provide situational awareness and technology for vital signs monitoring.

Ekso Bionics(TM) Secures Second Phase of U.S. Special Operation Command's TALOS Project

Ekso(TM) Labs Secures Third Contract With the U.S. Special Operations Command (SOCOM) for Upper Extremity TALOS Project (5/20/15)

Warrior Web Flexible Exoskeleton:
Ekso Bionics™ Selected for Development of Next-Generation DARPA Exoskeleton

Warrior Web A:
Testing for the Warrior Web Task A project culminated last week with six soldiers marching through 84 miles of obstacle filled terrain, carrying large loads, weapon and helmet. There were no incidences of failure reported.

Warrior Web B:

"Ekso Bionics (NASDAQ: EKSO), having successfully supplied technology to Warrior Web Task A, has been selected to participate in the second and concluding Warrior Web Task B.

Ekso Bionics will gain $4.5 million in the combined contract for both tasks." - RBR

Army R&D with RE2 Robotics:
(This is from a press release from RE2, not from Ekso Bionics. Ekso is simply jointly involved as mentioned below)
Note: EKSO is now on the NASDAQ exchange not the OTCBB

"The goal of the Phase II effort is to develop a simulation tool capable of producing validated biomechanical data on muscle forces, stresses, joint loads, and metabolic load that a human subject would have produced during load carriage with and without the use of a robotic exoskeleton. This data will help the Army analyze the benefits of exoskeletons and develop injury predictions.

“By directly modeling the interaction between a human user and the exoskeleton, our simulator will help to identify potential injury mechanisms and issues before any large-scale deployment of the device – ultimately reducing injuries while saving the Army time and money,” stated Jorgen Pedersen, president and CEO for RE2.

RE2 is partnering with biomechanical exoskeleton experts at Ekso Bionics™ (OTCBB: EKSO), neuromusculoskeletal simulation leader, Dr. Scott Delp and Dr. Jennifer Hicks, faculty at Stanford University, and the Human Engineering Research Laboratories at the University of Pittsburgh to design and test the Biomechanical Exoskeleton Simulator System."


EksoZeroG and Artemis (Construction/Tool Usage):


Ekso Bionics has spent several years designing and perfecting a range of ergonomic tool arms which are used to weightlessly manoeuvre heavy tools. These arms rely on spring tension and innovative design to balance the weight of tools used in drilling, sanding, riveting and many other applications. The Ekso Bionics Zero G arms are designed to hold loads of up to 19kg and fully balance the weight thus allowing the user to freely, safely and accurately manoeuvre the load in any direction without injury or fatigue.

The ergonomic tool arms have a variety of mounting options to suit the application including portable gantry’s, carts, jib arms, and linear rail. These systems require very little maintenance, no expensive inputs like electricity or compressed air, and have already been successfully used in a variety of industries from aerospace and defence to automotive manufacturing.

  • -Payback of less than a year
    -ROI of 100%
    -Less than 30 min of operator training required to achieve competency
    -No expensive inputs such as electricity or air required
    -Very minimal maintenance
    -Modular design for flexibility
    -13 different mobile and fixed mounting options
    -4 different arm configurations

There are several mounting options fro the Zero G ergonomic tool arms from ground based trolleys, to gantry mounts, jib crane mounts, linear rail and bench top mounting.

The Zero G ergonomic tool arm is used extensively in the aerospace,construction, mining and ship building industries in a range of roles. The weight balancing aspect of the Equipois Zero G system allows workers to grind, drill, chip surfaces easily for long periods of time even if the surface is in an overhead orientation.

Current users of the Equipois Zero G system include Airbus, Boeing, General Electric, BHP Billiton, Gammon Construction, Lockheed Martin, Chrysler, Ford, Honda, Nissan, Toyota, Caterpillar, John Deere, Bradken and many more.


Ekso Artemis:

"RICHMOND, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an exoskeleton company, today announced that it has completed the development of a lightweight, flexible load carriage exoskeleton prototype named Artemis."

Ekso Bionics Company Information:
-Founded in 2005 and headquartered in Richmond, CA 
--Originally Berkely Bionics of Univsity of California, Berkeley
-The current CEO is Thomas Loobyy
-Ekso is the industry leader in healthcare, military, and industrial exoskeletons
-The Ekso Bionics Ekso GT™ is the first and only FDA approved exoskeleton for stroke rehabiliation
-Over 190 international patent cases (granted or pending)

-Headquartered in the historic Ford Motor Company Assembly Plant, the largest wartime production assembly plant to be built on the West Coast
Company Presentation:

*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
Do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested. There are no guarantees when buying or selling any security.
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EKSO News: International Journal Spinal Cord Publishes Multicenter Pan-Euro Study of EksoGT™ 11/28/2017 08:00:00 AM
EKSO News: Statement of Changes in Beneficial Ownership (4) 11/27/2017 04:14:09 PM
EKSO News: Report: Developing Opportunities within OGE Energy, Stratasys, Snap, J.C. Penney Company, Inc. Holding, Micron Technology, an... 11/27/2017 07:55:00 AM
EKSO News: Proxy Statement (definitive) (def 14a) 11/24/2017 09:00:52 AM
EKSO News: Consolidated Research: 2018 Summary Expectations for Dow Chemical, Bank Of New York Mellon, New York Community, Frontier Comm... 11/16/2017 08:15:00 AM
#2381  Sticky Note On Talos: [continued "top level support" for the Rhetorical 08/16/16 07:02:33 PM
#4612   Read first post about EKSO and Apple,have you RainerRocks 12/10/17 08:11:01 PM
#4611 RainerRocks 12/10/17 08:08:44 PM
#4610   INTERVIEW W/ ERGONOMICS DECISION MAKER AT FORD: Rhetorical 12/09/17 05:54:07 PM
#4609 Rhetorical 12/09/17 04:36:55 AM
#4608 Rhetorical 12/09/17 04:36:35 AM
#4607   EKSO BIONICS ON VERGE!!!!!! Rhetorical 12/09/17 04:19:14 AM
#4606   Ford or any company will be looking to packerfan9 12/07/17 06:39:13 PM
#4605   It might be better the union bought exoskeletons Rhetorical 12/07/17 06:18:05 PM
#4604   That is a good thing because not fighting packerfan9 12/07/17 04:37:04 PM
#4603   It came from the union to try these out Lion33 12/07/17 03:45:00 PM
#4602   If Union is okay with this that is packerfan9 12/07/17 03:43:22 PM
#4601   That’s an assumption. A suggestion from the union Lion33 12/07/17 03:32:28 PM
#4600   wrong board RainerRocks 12/07/17 01:06:30 PM
#4599   Were on a roll 5 days straight Rhetorical 12/07/17 12:53:25 PM
#4598   It would make a big difference if the skepticone 12/06/17 10:02:25 PM
#4597   Please explain what you feel is significant about InnVest 12/06/17 08:35:58 PM
#4596   I don't see it making any difference who CIMA7 12/06/17 08:16:26 PM
#4595   All depends after buying them if it increases packerfan9 12/06/17 01:30:21 PM
#4594   I’m not sure if it was ever bought Lion33 12/06/17 12:47:22 PM
#4593   Just curious as to why Ford did not skepticone 12/06/17 12:35:39 PM
#4592   Yes it was, Union is actually trying to Lion33 12/06/17 10:57:54 AM
#4591   Something that I feel to be significant that skepticone 12/06/17 10:53:21 AM
#4590   Nice article Lion33 12/06/17 10:24:20 AM
#4589 skepticone 12/06/17 08:40:46 AM
#4588   OK.... accelerate it is. RainerRocks 12/05/17 06:58:47 PM
#4587   Ekso's coverage in the news is accelerating is Rhetorical 12/05/17 06:31:06 PM
#4586   What do you mean by more coverage ,who RainerRocks 12/05/17 05:51:09 PM
#4585   YAHOO, MOTLEY, AND SOON TO BE MORE COVERAGE Rhetorical 12/05/17 05:38:00 PM
#4584   Starting off the day with a good run, Railrazor63 12/05/17 10:16:54 AM
#4583 Rhetorical 12/04/17 08:28:27 PM
#4582   "...Government intends to solicit and negotiate with only Rhetorical 12/04/17 08:25:33 PM
#4581   See FBO analysis on competitive exoskeletons: Rhetorical 12/04/17 08:24:55 PM
#4580   Ekso's Vest has been out for 2 years+ Rhetorical 12/04/17 08:18:08 PM
#4579   Ford has to run their numbers before a Lion33 12/04/17 04:37:42 PM
#4578   Articles don't make it soar. Contracts and revenue golfblues 12/04/17 04:31:03 PM
#4577   I saw that myself, was about to post Lion33 12/04/17 04:30:36 PM
#4576   MOTLEY FOOL COVERS EKSO, GREAT FIND!!! Rhetorical 12/04/17 04:16:16 PM
#4575   FYI - Motley Fool mention: Eksobeans 12/04/17 07:47:48 AM
#4574   Someone most likely already posted this link ... PennyWorld 12/03/17 05:42:46 PM
#4573   It would seem Ekso's military contributions are largely Rhetorical 12/03/17 12:54:54 PM
#4572   oops// I didn't even look up at that, Lion33 12/03/17 02:54:53 AM
#4571   What goes down sometimes goes back up again =P Rhetorical 12/02/17 10:04:51 PM
#4570   I think it could see $2.00 again. Or, Uranium 12/02/17 02:38:22 PM
#4569 Rhetorical 12/02/17 02:22:23 PM
#4568   EKSO buy 2.350 stocktrademan 12/02/17 12:48:05 PM
#4567   Yeah, scroll up and look at the information Rhetorical 12/01/17 09:18:10 PM
#4566   Does EKSO have a hand in this Lion33 12/01/17 03:30:58 PM
#4565 Rhetorical 12/01/17 01:37:11 PM
#4564   That would not be considered a trading strategy. PennyWorld 12/01/17 09:34:45 AM
#4563   We seems to be on same boat. Give Frankz 12/01/17 08:16:45 AM